Cancer

BioNxt Completes “Fast-Track” US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis

VANCOUVER, BC / ACCESS Newswire / October 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...

Mindfulness Meditation Apps Market Set to Surge from USD 1.2 Billion in 2024 to USD 3.2 Billion by 2033, Experiencing a Robust CAGR of 14.5% – Market Research Intellect

The growth of the Mindfulness Meditation Apps Market is primarily driven by rising global awareness of mental health and wellness,...

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology...

Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium

Using Sapu Nano’s proprietary Deciparticle™ technology, Sapu-003 delivers everolimus intravenouslySYDNEY, Australia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN –...

Starton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation

PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with...

NEW RESEARCH FROM END WELL REVEALS TELEVISION SPARKS END-OF-LIFE CONVERSATIONS: VIEWERS SIGNIFICANTLY MORE LIKELY TO DISCUSS MORTALITY AFTER WATCHING AUTHENTIC STORYLINES

90% of Americans say end-of-life conversations are important, yet only 27% have had them - television storytelling emerges as a...

error: Content is protected !!